Marc Beer On Success In Entrepreneurship

It’s not always easy to be a successful businessman and entrepreneur but somehow Marc Beer
makes it easy. So what’s his secret to entrepreneurial success? Well, he recently gave advice to the
next generation of aspiring businesspeople. During this time, he reminded them of the importance
of having a solid financial strategy, learning from your past mistakes and, first and foremost,
always focus on giving back to the people in your community. He has only gotten as far as he has
by remaining pragmatic in the face of adversity, being willing to compromise for the success of the
company and, above all else, enjoying the process along the way. And of course, it never hurts to
fixate on the success of your company as that can be beneficial in the long run.
He began his academic career as a freshman at Miami University in the early ’80s. After graduating
with a bachelor of science in business degree, he accepted the first job offer he received and slowly
began working his way up the corporate ladder as he proved himself in the business world. That’s
why it came as no surprise to anyone when he started his own business in May of 2000 with him
serving as the founder and CEO. Headquartered in Cambridge, the primary mission of the company
was to obtain these stem cells from the umbilical cords of mothers who had just given birth to
analyze them in hopes of uncovering some potential vaccines or cures.
For a while, the company did pretty well for itself employing upwards of half a thousand people and
even going public just a few years after they launched. Shortly thereafter, it all went downhill as he
sold off the company for a whopping $300 million and left hundreds of people without jobs. Despite
being all set to move on to his next business venture, life threw him for a loop. It seems his wife
had contracted a pulmonary embolism and, despite the doctors doing everything they could, she
didn’t make it. After the mourning period, he tried to take a more central role in the lives of his
three children but they soon made him realize how important his career is. As such, in the autumn
of 2016, Renovia was born. Learn more:
As their chairman, co-founder and CEO, he ensured the company thrived under his leadership and
their main goal is to try and develop medical equipment to help patients who are suffering from
various diseases. One of their main missions is to try and treat pelvic floor disorders which affect
an estimated 25% of females throughout the country. Additionally, they just had their first product
receive a seal of approval from the FDA.

Connect with Marc Beer on Facebook


Marc Beer a Highly Accomplished Business Executive

Marc Beer is a highly accomplished business executive with over twenty years worth of
entrepreneurial experience. Beer for the over two decades he has been in the entrepreneurship
industry has helped establish a series of successful companies in the healthcare sector. Beer latest
successful business venture is Renovia Inc a Boston based med-tech Company that aims at
improving the care and treatment of pelvic floor disorders. Beer co-founded the company alongside
two experienced medical doctors Dr. Ray Iglesias and Yolanda Lorie. Dr. Ray Iglesias is an
experienced gynecologist with over thirty-five years worth of experience.

Dr. Ray Iglesias, for many years, had been performing pelvic floor surgeries and has been trying to
determine a way through which he can help women avoid surgery. After ten years of extensive
research and study, Dr. Iglesias and Yolanda invented a new surgery-free approach of treating
pelvic floor disorders. The two were experienced medical specialist and had little knowledge of
starting a business. They look around for a person who would help them roll out the business and
push the product into the market, and they settled on Beer. Beer has an excellent device
development and commercialization track record and was the perfect man for the job. Through a
phone call, Beer bought the idea and agreed to join the two in launching the company. Pelvic floor
disorder is a medical condition that affects the pelvic floor muscles making the tightening and
relaxation of the muscles difficult impairing the bowel and bladder control. There are three common
forms of pelvic floor disorders, and they include urinary incontinence that affects the bladder, fecal
incontinence that affects the bowels and pelvic organ prolapsed that causes the uterus bowel and
bladder to drop and bulge outside.

Marc Beer from research saw that pelvic floor disorder is a serious issue that affects millions of
women in the US and globally. From the research, Beer found out that between 2005 and 2006,
the amount spent by women in seeking treatment for the disorder amounted to 298 million dollars.
Beer from that knew that this is one industry that he could positively impact and help improve the
lives of women. Renovia Inc under Beer leadership has significantly grown within a few years of
establishment and already has one of its lines of products approved by the FDA. Beer has also
helped the firm raise Series A and Series B funding that will aid the firm in the commercial launch
of products as well as developing other lines of products.

Learn more:

Marc Beer besides Renovia has helped establish close to a dozen successful companies, and they
include ViaCell a Biotechnology company that he founded close to two decades ago and LumeNXT
LLC a Medtech firm that he co-founded in 2018. Beer has also served as a business executive in a
series of companies and they include Abbott laboratories, Genzyme, Myolex, Good Start Genetics,
and Minerva Neurosciences, among others.

Connect with Marc Beer on Facebook

Entrepreneur Marc Beer Explains Why He Paused His Career For Two Years

Marc Beer, an executive in the healthcare field, Marc Beer has led multiple biotechnology firms. He has been in this field for more than 25 years. He graduated from Mima University in 1987 where he studied business. His career began in pharmaceutical sales and marketing. This led to his first executive position as vice president of global marketing at Genzyme. This company developed treatments for rare diseases and he promoted their entire line of products.

He started his own company, ViaCell, in 2000. This was a very successful company that collected and preserved umbilical cord blood stem cells for researchers. These stem cells were used to develop treatments for all sorts of medical conditions. He sold the company for $300 million in 2007 to Perkins Elmer. 

Not long after he sold this company, his wife died when she was just 42 years old. He decided to stay at home and raise his three children. A few years later, Marc Beer’s daughter told him he needed to get back to work for his own good. He listened to her advice and soon co-founded Renovia. The company is developing treatments for women with a pelvic floor disorder.

Pelvic floor disorders are caused by five conditions. These include digestive diseases, interstitial cystitis, chronic pelvic inflammatory disease, endometriosis, and uterine fibroids. A woman with one of these conditions will experience symptoms such as urinary and fecal incontinence. Renovia is working on multiple treatments and one, Leva, has received FDA approval and is now on the market. Learn more:

Leva is a device with sensors and a supporting mobile app. Women use Leva to strengthen their pelvic muscles and to learn more about their condition. Leva’s successful launch helped Marc Beer raise $32 million for Renovia’s Series B round of funding. At the same time, he raised another $10 million in venture funding. Investors included Perceptive Advisors, Longwood Fund, and Ascension Ventures.

Marc Beer has used his professional success to give back to others. He has applied his business skills to help two scientific organizations. These are the Mass Life Science Board and the Biotechnology Innovation Organization. He was once on the board for Erytech Pharma and the Joe Andruzzi Cancer Foundation. He also lent his expertise to Minversa Neurosciences, Inc. which is a company that develops treatments for people who have a central nervous system disease.

Providing some advice to people who also want to be entrepreneurs, he says the first step is to create a financial plan. Be willing to make sacrifices to attain your vision and learn from your inevitable mistakes. Don’t let emotions guide your business decisions and enjoy the process of running a company. Also, give back to the community.

Follow Marc Beer on Facebook

Carsten Thiel Understands The Science of Molecules and Marketing


Carsten Thiel holds a Ph.D. in molecular biology from the Max Planck Institute. Thiel left his native Germany to study organic and biochemistry at the University of Bristol in England earning a Bachelor’s in biochemistry. Even though he is a scientist by training Carsten Thiel has a knack for sales and marketing.

Hoffman La-Roche

Thiel’s first job after college was with the Basel, Switzerland based biotechnology company Hoffman La-Roche. His first post at Hoffman La-Roche was Communications and Product Manager. For Carsten Thiel, his time with Hoffman La-Roche was both a learning and employment opportunity. Carsten Thiel gained knowledge in the areas of research and development, customer service, and marketing.


Xenical is the prescription version of the over-the-counter weight loss drug Alli. Xenical works by inhibiting the absorption of fat. To realize maximum results Xenical has to be taken as part of a diet and exercise regimen. When Hoffman La-Roche was ready to bring Xenical to market Carsten Thiel was charged with overseeing the marketing of Xenical. See This Page for additional information.

Carsten Thiel’s Strategy

There is a tendency to rush a new product to market with much hoopla and a touch of puffery. Carsten Thiel took a different approach to promote Xenical. Hoffman La-Roche would not depend on exaggerated promises to sell Xenical. Carsten Thiel focused on identifying the drug’s target market. Specifically, Thiel wanted prescribers to recommend Xenical to patients, who were most likely to make the lifestyle changes necessary to achieve maximum success with the drug. Prescriber and consumer education also factored into Thiel’s marketing strategy.


Carsten Thiel’s tactics were designed to slowly establish a positive reputation for Xenical. The slow and steady approach to marketing the drug paid-off. In its first year on the market, Swiss sales of Xenical equaled 1 billion francs.


Additional reference:


Carsten Thiel Takes Time With Family Before Business


Carsten Thiel had been surrounded by science and medicine since he was a child. As the son of medical doctors, he had always wanted to follow the footsteps of his parents and work in some part of medicine.

Thiel is now an expert in pharmaceuticals and biopharmaceuticals who has helped launch many different successful products throughout his career.

He was raised in Germany in a time that was still turbulent before he moved to the U.K. in order to pursue an education at the University of Bristol. While he was attending the school, he earned his bachelors and master’s degrees in organic chemistry and biochemistry. He went on to earn a Ph.D. from Max Planck Institute for Biophysical Chemistry for Molecular Biology.

Taking time out of his day to spend time with family is important for Carsten Thiel. Because his days can sometimes get quite busy and long, he makes sure to spend the mornings with them discussing their lives over breakfast and coffee. This is a good time to be able to get everyone’s schedule synched while relaxing before he starts his day. After spending time with his family, he reads the news and checks his emails. He stated that these activities are important and he tries to do them every day. Go To This Page to learn more.

It’s easy to become overwhelmed by everything that you need to do during your day which is why Carsten Thiel tries to prioritize. By making sure that Carsten Thiel is keeping his long-term goals in mind instead of just his short term, he is better able to accomplish what needs to be done. In addition, building relationships is important to any business which is why he spends another good part of his day communicating with customers and meeting with the board of the company to make sure everyone has the same goals.


Like him on

Carsten Thiel And Darrel P. Cohen Join EUSA Pharma

Dr. Carsten Thiel was recently appointed to the office of President of EUSA Pharma in Europe. Dr. Darrel P Cohen was also appointed as Head of EUSA’s Clinical Development Department.

EUSA is a company that focuses on creating pharmaceuticals that treat rare diseases. Both Dr. Cohen and Dr. Thiel have extensive educations and experience to fill these positions and strengthen EUSA’s structure globally in clinical development.

Carsten Thiel attended the University of Marburg and has a Masters in Biochemistry as well as a PhD in Molecular Biology from Max Planck Institute in Germany. Dr. Thiel started his career at Hoffman La Roche. He held several positions at Amgen.

During his time at Amgen, Dr. Thiel was responsible for the development of several products that treated bone disorders, nephrology, and oncology. Carsten Thiel followed this up with a few years working for Alexion Pharmaceuticals Inc. and prior to his position at EUSA Europe Dr. Thiel held the position of CEO at Abeona Therapeutics focusing on US gene-based therapies.

Darrel P. Cohen attended the Boston University School of Medicine where he obtained an MD and a PhD in Microbiology. He has held the position of Director for Clinical research for Sanofi- Aventis. Dr. Cohen previously led the Clinical Development Center of Pfizer’s global oncology as Vice president and was responsible for helping in the development of several oncology products that were quite successful. In his long career, Dr. Darrel P. Cohen has held the positions of Associate in Medicine and Hematology/ Oncology fellow at the Duke University Medical Center. Dr. Darrel P. Cohen brings 20 years of experience as a hematologist/oncologist in clinical development to EUSA. Go To This Page to learn more.


Learn more about Thiel on